by Truveta staff | Sep 13, 2024 | Data
Mother and child health are inherently interconnected, offering unique insights into how maternal health, behaviors, and exposures impact child outcomes. Unfortunately, the potential of this data has historically been limited by challenges in data collection, the long...
by Truveta staff | Aug 15, 2024 | Data
Psoriasis is more than just a skin condition – it’s a chronic, systemic disease that affects over 8 million people in the United States, profoundly impacting their quality of life. As a complex, immune-mediated disease, psoriasis presents a variety of challenges to...
by Truveta staff | Jul 30, 2024 | Data
By the time most women with ovarian cancer are diagnosed, 70-80% are already at an advanced stage of the disease. Despite declining mortality rates over the past decade, the 5-year survival rate for patients with ovarian cancer remains less than 30%. Sometimes...
by Truveta staff | Jun 17, 2024 | Data, News, Technology
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
by Truveta staff | Jun 14, 2024 | Data
One in every four US households has someone living with migraine. More than a severe headache, migraine is a complex neurological disorder impacting 39 million Americans with more than $36B lost each year in medical expenses and lost productivity. Despite its...
by Truveta staff | May 20, 2024 | Data
You probably know someone who will be diagnosed with prostate cancer in their lifetime. 1 in 8 men will develop prostate cancer, with a higher risk in Black and African American men and an overall increased risk after the age of 65. While most cases are not fatal,...
